We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thank you for your reply Andybe4.
To conclude, your "insight" in this stock is there will be volatility ahead. I watched a weather report last night and the weatherman explained there was going to weather today. He managed to report the weather without threatening to beat people up in a pub.
Best of luck seeking further attention xxx
needs to ask cityttrader probably?
Fruits, I have a strategy, as do we all.
My goal is aligned with yours right now, let’s just wait and we can all make up to 10 times our current money.
To be able to trade effectively, people need foresight.
It’s fine if you are a long term holder and investor, as long as SPRINTER is a success then Synairgen is a fantastic long term investment, likely to be taken over before long anyway, or team up with big pharma for royalties partnership (even better).
The £5 billion market cap I mentioned earlier with relation to Adagio’s current market cap would be a lower end potential takeover bid price anyway. But that depends on what the board and other players are partial to accept.
That’s £25 per share. Ample amount of profit for anyone on this board, whether one bought in at 10p or 240p.
We all know that SPRINTER is all that counts now. The stage is set with Omicron and all the pieces of the jigsaw puzzle are in place. The perfect storm is there. If SNG001 works effectively in SPRINTER then it is the final piece in the centre. We can all enjoy lots of money. Then when the volatility is due, I will let you know, don’t worry, after that, one is free to use or disregard my thoughts.
We all get very rich together.
"Depending on certain factors I might even give some advanced warning and an explanation as to why the volatility will come (but I will decide nearer the time)"
AndyB4 , why can't you lay your stall out now and give your explanation?
Lack of credibility springs to mind, read previous posts.
gunto, two things, I’ve said before to you but for some reason you can’t get this through your skull:
1. If you won’t say something in real life to someone, don’t say it over the keyboard. That’s pathetic. That goes for quite a few others on here.
It’s a general rule that adults should adhere to online, one doesn’t know who they are talking to.
2. Again, the most IMPORTANT of the points.
Regardless of what conspiracies or ramping/de ramping nonsense you want to conjure up.
FOR NOW we have complete alignment in what we want. The SP to go way up.
I’ve already told people to prepare for volatility in the future. Depending on certain factors I might even give some advanced warning and an explanation as to why the volatility will come (but I will decide nearer the time). But for now, it’s all about getting that SP up.
We are all in this to make money, lots of money.
Gunto, Andybe4’s original post at 3.02am (he/she obviously can’t sleep!) I maintain was a useful post. 25 other members obviously agree by recommending it.
I do agree that they flip and flop between being super positive and then super nervous. But I see many posters on here who spread worse nonsense. Those that can spot trading patterns and predict TR1’s (that still haven’t materialised!).
LTH’s who deserve to see SNG succeed will be fully aware of which posters they should and shouldn’t listen to.
"I do think Andybe4 has been treated a bit harshly here"
Nobody has treated this poster harshly. For a few months they were pushing a negative narrative against the following:
* Phase 3 Hospital last dosing in severe delay. Is it now 2022?
* ACTIV-2 P3, have Synairgen not made it?
* Delta in-vitro, have Synairgen failed on this and was there a leak?!
Now they have turned all positive:
* Amazing idea to pump the stock on Reddit
* Comparison to an American mAB therapy enjoying a 300% rise
Call them out and they will suggest you should be beaten up in a pub and spouts a load of rubbish about anonymous people on internet saying nasty things to people.
He also once pretended to be a woman to gain sympathy / credibility. Sure doesn't write like a woman threatening to beat people up in pubs.
So what? Well the poster is most likely a desperate swing trader who keeps getting it wrong. The desperation is visible in the manner they lose patience with people and childish threats of violence.
Why should you care? Not everyone invested in Synairgen understands the science fully. Others do not have the time to catch up on the latest progress. So when you get complete nonsense posts like the in-vitro Delta failure leak, people have to speak up. Docdaneeka hit the nail on the head about them after the Delta post. Go and have a read of it, titled "Andybe - blown for the last time."
Stop recommending their posts and responding. This forum will benefit from it.
you can just about hear the clap of two large men's hands over the din
I do think Andybe4 has been treated a bit harshly here. I wasn’t aware of Adagio Therapeutics but have now done some reading and it further highlights the potential prices SNG could achieve with a successful P3.
Adagio is yet another injection (that people will likely be sceptical about) and isn’t as far along in the development cycle as SNG, yet has a market cap getting on for 10x more.
Agreed Andybe4.
I have no fundamental disagreement with anything you have said today, and fully concur with your important point regarding the disparity in the valuation of the two companies.
My point was that unless some unfair practices are brought to bear, Synairgen should be well on its way before the P2 results for Adagio Therapeutics’ product are known.
It would be dangerous to bring a product to market before it is fully tested. When one reflects on all the hoops that Synairgen has leapt through to reach the current stage, would anyone wish to use an under-trialled product? There could at the very worst be consequences which were equally dangerous as those from the virus that it was treating?
Regards and good wishes.
In my book it's just 'Merican noise; Adagio currently can offer their VC backers NO confidence that their drug offers protection against the Omicron variant. Not yet. And there's still an IF. Furthermore, their timeline is massively behind ours: Adagio anticipates that the data package to support an EUA for ADG20 will be available in the second quarter of 2022 followed by expected submission to the FDA in the third quarter of 2022.
A non-issue IMO.
@Ndn that's also my concern, that after the price surge it'll be difficult to sell - but as you said, it's about what happens in the moment and/or price limit.
I understand your sentiment Andybe4 but it doesn’t need pumping prior to results. In time true value will assert itself. I agree that compared to most US biotech SNG is laughably undervalued. But it also speaks of our general mindset here in the UK vs the investment habits of the US.
We don’t need to turn SNG into a casino in the run up to results. Leave it be and watch the fireworks come results. No use trying to pump it now.
Alkin and TLwilliams, you seem to have completely missed the point.
Adagio are currently in phase 2 trials for a variant agnostic antibody treatment.
Synairgen have virtually completed their Phase 3 trial of their variant agnostic antiviral inhaled therapy.
Adagio currently has a market cap of 5 billion dollars and Synairgen that are a lot further along than Adagio have a market cap of 400 million, pittance of the investment in Adagio.
So somewhere along the line, our product clearly is not getting the publicity it needs to garner more investment, like the investment that the US biotech firms generate.
If Adagio can be worth 5 billion dollars and increase 300% in a few days based on minor news. Synairgen should be worth MORE than Adagio.
TLwilliams, you say it’s not a contest, but everything is a contest in order to get the product out to market first and make profit. Synairgen is well ahead of Adagio, but the point is it’s worth 10 times less than Adagio.
That’s a serious serious mismatch in price. Synairgen is seriously undervalued.
Why is Synairgen so undervalued compared to US biotech companies which have inferior products?
This remains to be seen.
Based on the 300% rise in the last few days that Adagio had, if Synairgen board promotes SNG001 after an efficacious SPRINTER readout, we can go up to at least 5 billion market cap.
This should not be perceived as a contest. Adagio Therapeutics’s anti viral solution is well behind Synairgen’s in all respects, their trial trajectory being the most significant. A decent Synairgen P3 readout will render their product an irrelevance to our future success.
This is bull if you check the actual prices
Looking at SP for these, they were up to $53 in September now $46.
Looking to have P2 data in first quarter of 2022.
Only thing of value in this post is that SNG should be higher, suppose that is the difference between the Nasdaq and AIM
Oakleaf 72 Are you crackers<' Adagio Therapeutics shares rose 69% 2 days ago And that was just one day
Sure Ndn, that would be sensible but it appears I am too greedy :)
Sure is Oak. I take it as a sign something good is gonna happen today ;-)
BeContrarian, I’m with you into the longer term, if positive SPRINTER, I believe the underpinning value would be there in sales. Planning to hold but I admit I would be sweating, as the value held would be large (in my life) in that scenario. I would also be at the End of the Rainbow party in the summer!
Adagio has not increased 300% and barely at all.
TAG TEAM DE-RAMP ALERT
Andy, I tend to agree with you for the reasons you have given. I think this share will either rise very significantly on SPRINTER results or drop by 70-80%. Anything close to replicating our hospital P2 data will significantly gap £5 within days. The projected dividend streams will support that, IMHO